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Abstract: Noroviruses are a major cause of gastroenteritis outbreaks worldwide. Norovirus 
outbreaks frequently occur as epidemics which appear to be related to both genetic and 
environmental factors. This review considers recent progress in understanding these factors. 
The norovirus genome undergoes continuous change and this appears to be important in 
the persistence of the virus in the community. Studies on the common GII.4 genotype have 
shown that some norovirus outbreak epidemics involving this genotype are correlated with 
specific changes in the genome. In contrast to the growing understanding of the role of 
genetic factors in norovirus outbreak epidemics, the role of environmental factors is less 
well understood. Topics reviewed here include long term excretion of norovirus in some 
individuals,  long  term  survivability  of  norovirus  in  the  environment,  the  role  of 
meteorological  factors  in  the  control  of  norovirus  outbreaks  and  the  possible  zoonotic 
transmission of the virus. 
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1. Introduction 
The  noroviruses,  which  are  single-stranded  positive  sense  RNA  viruses  classified  in  the  genus 
Norovirus  within  the  family  Caliciviridae  [1],  are  now  considered  the  most  common  cause  of 
outbreaks  of  non-bacterial  gastroenteritis  worldwide  [1],  as  well  as  being  an  important  cause  of 
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sporadic gastroenteritis [1]. Epidemics of norovirus outbreaks, which can be defined as peaks in the 
incidence of outbreaks above the general level [2,3], are well established [3-5]. Norovirus outbreak 
epidemics  can  show  an  annual  cyclic  periodicity  [3-5]  and  the  dynamics  of  norovirus  outbreak 
epidemics appear to be dependent on a complex interaction of different variables which include both 
genetic and environmental factors [4].  
This  review  examines  recent  progress  in  understanding  the  roles  of  genetic  and  environmental 
factors in the control of the incidence of norovirus outbreak epidemics. The term “genetic” refers 
principally to nucleotide changes in the norovirus genome. Two main topics are reviewed here. Firstly, 
general  aspects  of  genetic  change  in  the  norovirus  genome  and  their  relationship  to  altered 
infectivity/virulence of the virus are considered. Secondly, numerous recent studies linking genetic 
changes in the GII.4 genotype to changes in the pattern of outbreak epidemics linked to this genotype 
are reviewed. Topics reviewed in the category of “environmental factors” include norovirus excretion 
patterns, norovirus survivability in the environment, the role of meteorological factors in the control of 
norovirus outbreak epidemics and the possible zoonotic transmission of norovirus.  
2. Genetic Factors 
2.1. General 
The norovirus genome is approximately 7.6 kb in length and typically comprises three open reading 
frames (ORFs) [1]. ORF 1 encodes the non-structural polyprotein, ORF 2 encodes the major structural 
capsid protein and ORF 3 encodes a small virion-associated protein [1]. Recent studies indicate that 
murine norovirus has an additional ORF, ORF 4, which overlaps ORF 2 [6]. 
Noroviruses are currently classified into five genogroups [7,8]. Three of these, genogroups I, II and 
IV (GI, GII and GIV), occur in human infections [9,10] though most noroviruses affecting humans 
belong to GI or GII [11]. Within each genogroup one or more “clusters” or “genotypes” have been 
identified [7,9,10]. In a major review of norovirus classification, Zheng et al. [7] examined 164 amino 
acid sequences from the capsid region of both human and animal noroviruses. These authors identified 
five  genogroups  comprising  29  genotypes,  with  eight  genotypes  in  GI,  17  in  GII,  two  in  GIII,  
and one each in GIV and GV. More recently, Patel  et al. [8] identified 32 genotypes among the  
five genogroups. 
The major capsid protein encoded by ORF 2, which is referred to as VP1, is of considerable interest 
because it is believed to be involved in the recognition of the host receptor [12,13]. VP1 includes a 
shell and a protruding (P) domain, which, in turn, is made up of P1 and P2 subunits [10]. The P2 
subunit  is  considered  critical  for  receptor  binding  [10,12].  It  has  been  proposed  that  amino  acid 
changes in the P2 domain allow the virus to reinfect an individual (e.g., by host cell receptor switching) 
and thereby escape herd immunity [14]. 
The norovirus genome undergoes frequent change [15,16] by mechanisms including mutation [17] 
and  recombination  [18].  Although  the  relative  importance  of  mutation  vs.  recombination  in  the 
evolution  of  norovirus  remains  unclear  [19],  there  appears  to  be  no  doubt  that  recombination  is 
important.  For  example,  Bull  et  al.  [18]  identified  20  norovirus  recombinant  types  in  circulation Int. J. Environ. Res. Public Health 2011, 8                 
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worldwide  and  Motomura  et  al.  [20]  have  suggested  that  recombination  could  be  an  important 
mechanism by which GII.4 remains persistent in human populations. 
There  is  now  some  evidence  that  a  small  genetic  change  in  the  capsid  region  can  have  a  
big influence on norovirus virulence. Bailey et al. [21] found that murine norovirus virulence was 
linked to a glutamate to lysine substitution in the capsid region. Various nucleotide changes in other 
parts of the genome have also been linked to changes in norovirus virulence. For example, there is 
some evidence that nucleotide changes in the polymerase region of human GII.4 noroviruses may 
influence virulence [22-24]. 
2.2. Studies on GII.4 Variants  
GII.4 norovirus is the most common cause of human norovirus outbreaks worldwide [25] and GII.4 
noroviruses have been the focus of much genetic research. GII.4 strains frequently undergo genetic 
change and these altered forms are sometimes termed “variants” [25-27] or “subtypes” [20]. There is 
some evidence that the emergence of new GII.4 variants can correlate with the occurrence of norovirus 
outbreak epidemics. For example, the appearance of the GII.4 “Hunter” variant in Australia in 2004 
coincided with an increase in norovirus outbreak activity [25]. Kroneman et al. [28] reported that an 
increase in gastroenteritis outbreaks in the Netherlands in 2004 was linked to the appearance of the 
GII.4 “GII.4-2004” variant. Ho et al. [29] reported a norovirus outbreak epidemic in 2006 in Hong 
Kong was linked to the emergence of the GII.4 “95/96-like” variant.  
Variants have been identified as a cluster in either the GII.4 ORF 1 phylogenetic tree [3] or in the 
GII.4 ORF 2 phylogenetic tree [25]. In a study spanning 2002 to 2007 Bruggink and Marshall [3] 
found that each GII.4 norovirus outbreak epidemic was linked to one of four variants identified and 
there was a time link, a delay of 2 to 6 months, between the first detection of a GII.4 variant and the 
first outbreak epidemic in which it was the principal variant. It should be noted that the same GII.4 
variant could be the principal variant in norovirus outbreak epidemics in successive years, so that the 
appearance of new variants cannot explain the annual cycle of GII.4 norovirus outbreak epidemics, 
thereby  suggesting  that  environmental  factors  are  important  in  the  initiation  of  an  epidemic  
(see Section 3.4). 
3. Environmental Factors 
3.1. General 
Noroviruses  can  be  spread  by  contaminated  food  or  water,  person-to-person  contact  [10]  or  
aerosols  [30,31].  Noroviruses  are  usually  detected  in  faeces  but  have  also  been  detected  in  
vomitus [10] but apparently not in nasopharyngeal washings [10]. Norovirus-associated gastroenteritis 
outbreaks can occur in virtually any situation where groups of individuals gather together, including 
child-minding centres, school outings, camps, restaurants, hospitals, hostels, nursing homes, prisons 
and cruise ships [10,32,33]. The mode of spread of norovirus, its ubiquitous nature and the regular 
periodicity of norovirus outbreak epidemics [3-5] suggest environmental factors are important in the 
spread of the virus and some key topics here are considered next. 
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3.2. Norovirus Excretion Patterns 
Norovirus  excretion patterns  may  play an  important  role  in the spread of the virus.  Some  key 
findings  follow.  There  is  now  evidence  that  norovirus  RNA  or  virion  excretion  can  occur  in  the 
absence of major symptoms of gastroenteritis. For example, norovirus RNA or virion excretion can 
occur  after  major  symptoms  have  abated  [34-36]  and  there  is  a  report  in  which  norovirus  RNA 
excretion  was  found  in  an  individual  the  day  before  the  onset  of  symptoms  [36].  Furthermore, 
volunteer  studies  indicate  that  norovirus  can  be  detected  in  infected  individuals  with  no  major 
symptoms  [37] but  studies  of the asymptomatic excretion of norovirus RNA in  naturally infected 
individuals indicate the percentage of asymptomatic excretors appears to depend on the population 
being  sampled  [38-40].  Norovirus  excretion  can  continue  for  long  periods.  Norovirus  has  been 
detected up to seven days after inoculation of virus in one volunteer study [37] and norovirus RNA for 
up  to  44.5  days  following  onset  of  symptoms  in  a  naturally  infected  individual  [41].  Prolonged 
norovirus RNA excretion is well documented in immunocompromised individuals [42-44]. 
3.3. Norovirus Survivability in the Environment 
A  number  of  studies  have  examined  norovirus  survivability  in  the  environment.  As  human 
norovirus cannot be grown reliably in culture [45], a variety of approaches have been tried including 
the use of cultivable norovirus surrogates [46,47] or the application of a human norovirus “infectivity 
assay”, which does not involve a culture system [48]. Taken together all the approaches used indicate 
norovirus can survive for long periods in the environment. A brief review of some key studies follows. 
Doultree et al. [46] used feline calicivirus as a norovirus surrogate in studies on the survivability of 
the virus in a variety of conditions. These authors found that the virus survived for at least 60 days  
at 4 ° C with minimal loss of infectivity. At room temperature feline calicivirus was stable for 14  
to 21 days in suspension in culture medium and 21 to 28 days in the dried state.  
Bae and Schwab [47] compared the survivability of feline calicivirus with that of murine norovirus 
in water and concluded that murine norovirus had significantly higher rates of survivability than those 
of feline calicivirus.  In particular, infectivity reduction at  25  °C  was  greater  for feline calicivirus  
(0.18 log10/day) than for murine norovirus (0.09 log10/day). Similarly, nucleic acid reduction rates  
at  25  °C ,  determined  using  a  multiple  linear  regression  model,  were  higher  for  feline  calicivirus  
(0.08 ±  0.03 log10/day) than for murine norovirus (0.04 ±  0.03 log10/day). However, caution is needed 
in assuming murine norovirus is the ideal surrogate for human norovirus in such studies. Tan and  
Jiang [13] and Lay et al. [49], for example, note that there appear to be important differences between 
human and murine noroviruses. These differences include the areas of clinical manifestation, host 
receptors, range of cell types where replication occurs and pathogenesis.  
Lamhoujeb  et  al.  [48]  used  human  norovirus  to  study  the  survivability  of  norovirus  on  
“food-contact” surfaces such as stainless steel and polyvinyl chloride. In their study, the identification 
of putatively infectious and noninfectious norovirus was based on an assay which utilized enzymatic 
pre-treatment of the virus such that noninfectious virus was believed to have been removed. On this 
basis the authors concluded that human norovirus could remain infectious for up to 28 days on both 
surface types at 20 ° C. Int. J. Environ. Res. Public Health 2011, 8                 
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3.4. Meteorological Factors 
Currently there is little understanding of what environmental factors may correlate with the annual 
cycle of norovirus outbreak epidemics, but there is now some information on temperature and rainfall. 
Current evidence indicates temperature is not one of these factors, as norovirus outbreak epidemics 
tend to occur in colder months of the year in the northern hemisphere [50] and warmer months of the 
year in the southern hemisphere [4,32]. On the other hand there is evidence noroviruses can be spread 
by waterborne methods [51,52], thereby suggesting rainfall may be able to play a role in the control of 
norovirus outbreaks. Recent evidence  supports  this hypothesis.  Bruggink  and  Marshall  [53] found 
there  was  a  statistically  significant  correlation  between  monthly  norovirus  outbreak  incidence  and 
average rainfall in a 2002–2007 study in Australia. It was found there was a lag of about three months 
between peak average rainfall and a norovirus outbreak epidemic following in the same calendar year. 
These results suggest that there is an environmental reservoir for norovirus and that rain, perhaps by 
altering the turbidity of reservoirs of water-borne norovirus, stimulates the spread of norovirus in the 
community and thereby helps initiate an outbreak epidemic.  
3.5. Zoonotic Transmission of Norovirus? 
Norovirus  has  been  detected  in  a  variety  of  animals  including  pigs  [12,54,55],  cattle  [12],  
mice [12,56], dogs [57-60], sheep [55] and a lion [61]. The genogroups associated with human and 
animal noroviruses are as follows. GI norovirus has been linked to humans [57], GII norovirus to 
humans  [57],  pigs  [57]  and  cattle  [62],  GIII  norovirus  to  cattle  [12,57,62]  and  sheep  [55],  GIV 
norovirus to humans [57], a lion [61] and dogs [57,60] and GV norovirus to mice [57]. It has been 
suggested that there is at least one additional norovirus genogroup, and that viruses in this group occur 
in dogs and humans [58,59]. 
A key public health question in this area is whether animals can act as a reservoir for human 
noroviruses. In a review of the literature, Koopmans [45] noted that, although zoonotic transmission of 
noroviruses  had  not  been  observed,  the  current  understanding  of  norovirus  epidemiology  was  too 
limited to be sure this did not occur. 
4. Conclusions 
It is now established that the norovirus genome undergoes frequent change and there is evidence 
that some of these changes are linked to altered viral infectivity. However, there is also evidence that 
environmental factors are important in the spread of norovirus. Future studies should not neglect the 
potential importance of environmental factors in developing a full understanding of the dynamics of 
norovirus outbreak epidemics. 
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